SAN FRANCISCO (BUSINESS WIRE) Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced that it will participate in a webinar on Unlocking the Value o.
08.06.2022 - Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced that the U.S. Patent and .
Equities analysts forecast that Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) will announce earnings of ($0.47) per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Better Therapeutics’ earnings. The lowest EPS estimate is ($0.51) and the highest is ($0.42). The company is scheduled to report its next quarterly earnings […]
Pear Therapeutics (NASDAQ:PEAR – Get Rating) and Better Therapeutics (NASDAQ:BTTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Pear Therapeutics and Better Therapeutics’ […]
Talkspace (OTCMKTS:TALK – Get Rating) and Better Therapeutics (NASDAQ:BTTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation. Analyst Ratings This is a breakdown of current ratings and […]